Mortality of midlife women with surgically verified endometriosis-a cohort study including 2.5 million person-years of observation

Show full item record



Permalink

http://hdl.handle.net/10138/317243

Citation

Saavalainen , L , But , A , Tiitinen , A , Härkki , P , Gissler , M , Haukka , J & Heikinheimo , O 2019 , ' Mortality of midlife women with surgically verified endometriosis-a cohort study including 2.5 million person-years of observation ' , Human Reproduction , vol. 34 , no. 8 , pp. 1576-1586 . https://doi.org/10.1093/humrep/dez074

Title: Mortality of midlife women with surgically verified endometriosis-a cohort study including 2.5 million person-years of observation
Author: Saavalainen, L.; But, A.; Tiitinen, A.; Härkki, P.; Gissler, M.; Haukka, J.; Heikinheimo, O.
Contributor: University of Helsinki, Faculty of Medicine
University of Helsinki, Department of Public Health
University of Helsinki, HUS Gynecology and Obstetrics
University of Helsinki, HUS Gynecology and Obstetrics
University of Helsinki, Department of Public Health
University of Helsinki, HUS Gynecology and Obstetrics
Date: 2019-08
Language: eng
Number of pages: 11
Belongs to series: Human Reproduction
ISSN: 0268-1161
URI: http://hdl.handle.net/10138/317243
Abstract: STUDY QUESTION Is all-cause and cause-specific mortality increased among women with surgically verified endometriosis? SUMMARY ANSWER The all-cause and cause-specific mortality in midlife was lower throughout the follow-up among women with surgically verified endometriosis compared to the reference cohort. WHAT IS KNOWN ALREADY Endometriosis has been associated with an increased risk of comorbidities such as certain cancers and cardiovascular diseases. These diseases are also common causes of death; however, little is known about the mortality of women with endometriosis. STUDY DESIGN, SIZE, DURATION A nationwide retrospective cohort study of women with surgically verified diagnosis of endometriosis was compared to the reference cohort in Finland (1987-2012). Follow-up ended at death or 31 December 2014. During the median follow-up of 17years, 2.5 million person-years accumulated. PARTICIPANTS/MATERIALS, SETTING, METHODS Forty-nine thousand nine hundred and fifty-six women with at least one record of surgically verified diagnosis of endometriosis in the Finnish Hospital Discharge Register between 1987 and 2012 were compared to a reference cohort of 98824 age- and municipality-matched women. The age (meanstandard deviation) of the endometriosis cohort was 36.49.0 and 53.612.1years at the beginning and at the end of the follow-up, respectively. By using the Poisson regression models the crude and adjusted all-cause and cause-specific mortality rate ratios (MRR) and 95% confidence intervals (CI) were assessed. Calendar time, age, time since the start of follow-up, educational level, and parity adjusted were considered in the multivariate analyses. MAIN RESULTS AND THE ROLE OF CHANCE A total of 1656 and 4291 deaths occurred in the endometriosis and reference cohorts, respectively. A lower all-cause mortality was observed for the endometriosis cohort (adjusted MRR, 0.73 [95% CI 0.69 to 0.77])-there were four deaths less per 1000 women over 10years. A lower cause-specific mortality contributed to this: the adjusted MRR was 0.88 (95% CI 0.81 to 0.96) for any cancer and 0.55 (95% CI 0.47 to 0.65) for cardiovascular diseases, including 0.52 (95% CI 0.42 to 0.64) for ischemic heart disease and 0.60 (95% CI 0.47 to 0.76) for cerebrovascular disease. Mortality due to alcohol, accidents and violence, respiratory, and digestive disease-related causes was also decreased. LIMITATIONS, REASONS FOR CAUSATION These results are limited to women with endometriosis diagnosed by surgery. In addition, the study does not extend into the oldest age groups. The results might be explained by the characteristics and factors related to women's lifestyle, and/or increased medical attention and care received, rather than the disease itself. WIDER IMPLICATIONS OF THE FINDINGS These reassuring data are valuable to women with endometriosis and to their health care providers. Nonetheless, more studies are needed to address the causality. STUDY FUNDING/COMPETING INTEREST This research was funded by the Hospital District of Helsinki and Uusimaa and The Finnish Medical Foundation. None of the authors report any competing interest in relation to the present work; all the authors have completed the disclosure form.
Subject: mortality
endometriosis
cause-of-death
cardiovascular mortality
cancer mortality
ALL-CAUSE MORTALITY
NONSTEROIDAL ANTIINFLAMMATORY DRUGS
BODY-MASS INDEX
QUALITY-OF-LIFE
BREAST-CANCER
OVARIAN CONSERVATION
SOCIOECONOMIC-STATUS
SYSTEMATIC ANALYSIS
GLOBAL BURDEN
RISK
3123 Gynaecology and paediatrics
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
LSaavalainenEndometriosis_Mortality.pdf 1003.Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record